[Viva] Fwd: HIV Weekly, 3 April 2013

Margarite Sanchez margaritesanchez at gmail.com
Wed Apr 3 11:28:15 PDT 2013 

Info on HPV & more ...


---------- Forwarded message ----------
From: <hivweekly at nam.org.uk>
Date: Wed, Apr 3, 2013 at 3:46 AM
Subject: HIV Weekly, 3 April 2013
To: margaritesanchez at gmail.com


    Having problems reading this email? View it in your browser
>><http://www.aidsmap.com/page/2620918/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
   [image: HIV weekly]<http://www.aidsmap.com/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>

03 April 2013

   - HIV and HPV <#13dcf8682070fde4_item2620919>
   - The benefits of a cup of coffee <#13dcf8682070fde4_item2620923>
   - Editors' picks from other sources <#13dcf8682070fde4_item2620924>


<http://www.aidsmap.com/donate?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>

 HIV and HPV

 HIV treatment and clearance of HPV

Successful HIV treatment reduces the risk of persistent cervical infection
with human *papillomavirus*, Belgian researchers
report<http://www.aidsmap.com/Long-term-suppression-of-viral-load-and-sustained-CD4-cell-increase-reduce-risk-of-cervical-HPV-infection-for-HIV-positive-women/page/2601617/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>.


Although still rare, rates of
cervical<http://www.aidsmap.com/Cervical-cancer/page/1044649/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>and
anal
cancer<http://www.aidsmap.com/Anal-cancer/page/1044631/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>are
much higher in people living with HIV compared to people in the
general
population.

Both these cancers are linked to infection with strains of human *
papillomavirus*
(HPV)<http://www.aidsmap.com/Human-papillomavirus/page/1731709/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>.
HPV is very common and most people will have it at some point in their
lives. For most people, infection with HPV will cause no symptoms or
problems and will go away on its own.

There are many different strains of HPV and persistent infection with
high-risk strains of HPV can lead to the development of abnormal cells in
the cervix or anus. These cells are not cancerous, but they have the
potential to develop into cancer if not identified and, if necessary,
treated.

Now doctors in Belgium have found that successful HIV
treatment<http://www.aidsmap.com/HIV-treatment/page/1044497/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>reduces
the risk that infection with high-risk strains of HPV will persist.

They monitored 652 women living with HIV who had regular cervical
screening<http://www.aidsmap.com/Cervical-and-anal-screening/page/1733203/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>(smear
tests) between 2002 and 2011. Over three-quarters were taking HIV
treatment.

At the start of the study, 43% of women had high-risk cervical HPV
infection. This appeared to be associated with the health of the immune
system: 63% of those with a CD4 cell
count<http://www.aidsmap.com/CD4-cell-counts/page/1044596/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>below
200 had high-risk HPV infection compared to 28% of those with a CD4
cell count above 500.

The women were monitored for an average of 8.5 years.

An undetectable viral
load<http://www.aidsmap.com/Viral-load/page/1044622/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>for
at least 24 months and a sustained increase in CD4 cell count above
500
were both associated with the clearance of infection.

Improvements in immune function that accompany successful HIV treatment are
likely to explain these findings.

*All women are recommended to have **regular cervical
screening*<http://www.aidsmap.com/Cervical-and-anal-screening/page/1327450/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
*. Women with HIV (aged 25-65) in the UK are recommended to have annual
cervical screening. This should be offered as part of routine HIV care and
is also available from GPs.*

*For information and support around cervical cancer, visit the Jo’s Trust
website <http://www.jostrust.org.uk/>.*
 Pre-cancerous anal lesions in gay men

Separate research found a very high incidence of anal lesions among gay men
living with HIV in
Thailand<http://www.aidsmap.com/Very-high-incidence-of-high-grade-pre-cancerous-anal-lesions-among-young-HIV-positive-Thai-gay-men/page/2612572/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>.


As with cell changes in the cervix (see previous story), infection with
high-risk strains of human *papillomavirus* (HPV) is associated with
changes to cells in the anus, some of which have the potential to develop
into cancer.

The research involved 123 HIV-positive and 123 HIV-negative gay men who
were recruited in Bangkok. Only 13% of the HIV-positive men were taking
antiretroviral therapy.

At the start of the study, 19% of those with HIV as well as 13% of the
HIV-negative men had high-grade pre-cancerous anal
lesions<http://www.aidsmap.com/Anal-HPV-and-cancer-in-gay-men/page/1732143/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
.

The study lasted one year. During this time, 27% of the men with HIV and 7%
of HIV-negative men developed high-grade anal lesions.

High rates of disease progression (33%) were seen in HIV-positive men who
had low-grade anal lesions at the start of the study.

Persistent infection with high-risk strains of
HPV<http://www.aidsmap.com/Human-papillomavirus-warts-and-genital-cancers/page/1731952/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>(HPV-16/18)
increased the risk of high-grade lesions by a factor of five.

*Regular sexual health screens are recommended for all HIV-positive gay
men. This should involve an examination of the anus to check for any
abnormalities. **Screening for anal cell changes and
lesions*<http://www.aidsmap.com/Cervical-and-anal-screening/page/1733203/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
* may also be available as part of your routine HIV care.*

*Find out more about screening for anal cancer in ‘Everything okay down
there?’<http://www.aidsmap.com/Everything-okay-down-there-Screening-for-anal-cancer/page/2020142/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
*
  The benefits of a cup of coffee

Drinking coffee may do more than wake you up in the morning.

Researchers have found good evidence that drinking coffee reduces the risk
of liver cancer by
half<http://www.aidsmap.com/Drinking-coffee-halves-the-risk-of-liver-cancer/page/2597690/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>.


They reviewed the results of 16 separate studies. Overall, people who drank
coffee were about 50% less likely than non-coffee-drinkers to develop liver
cancer<http://www.aidsmap.com/Liver-cancer-hepatocellular-carcinoma/page/1731909/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>.


The findings of this study add to the evidence suggesting that drinking
coffee has benefits for the health of the
liver<http://www.aidsmap.com/The-liver/page/1045123/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>,
and are therefore likely to be of particular interest to people living with
HIV who have hepatitis
B<http://www.aidsmap.com/The-liver/page/1045123/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>or
hepatitis
C<http://www.aidsmap.com/Hepatitis-C/page/1045186/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>co-infection.
The benefits seem to be connected to chemicals in caffeine.

Research has already shown that drinking three or more cups of coffee each
day is associated with an improved response to hepatitis C therapy for
people with hepatitis C
mono-infection<http://www.aidsmap.com/Coffee-drinking-improves-hepatitis-C-treatment-response-rate-in-mono-infected-patients/page/1836432/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
.

Other research showed that coffee consumption reduced the incidence of
side-effects in people with HIV and hepatitis C co-infection taking
hepatitis C therapy by up to
80%<http://www.aidsmap.com/Coffee-consumption-reduces-side-effects-in-people-on-hepatitis-C-treatment/page/2074096/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>.


*For more information on HIV and hepatitis C co-infection you may find our
HIV & hepatitis booklet useful. Visit
www.aidsmap.com/booklets<http://www.aidsmap.com/booklets?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>.
*
 Editors' picks from other sources
NHS reforms: From today the Coalition has put the NHS up for
grabs<http://www.aidsmap.com/Aggregator.ashx?type=bulletin&url=http%3a%2f%2fwww.telegraph.co.uk%2fhealth%2fhealthnews%2f9962195%2fNHS-reforms-From-today-the-Coalition-has-put-the-NHS-up-for-grabs.html&utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>

from Daily Telegraph

Under the Coalition's reforms, the NHS’s former strengths are being
replaced by a fragmented service, bound not by what is best for the patient
but by cost.
HIV/AIDS, TB rates sap Russian
health<http://www.aidsmap.com/Aggregator.ashx?type=bulletin&url=http%3a%2f%2fwww.washingtonpost.com%2fworld%2feurope%2fhivaids-tb-rates-sap-russian-health%2f2013%2f03%2f28%2fa20f8cb4-919c-11e2-bdea-e32ad90da239_story.html&utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>

from Washington Post

Russia considers itself a robust member of the global community, keeping
pace with heavyweights such as the United States and China. But when it
comes to health, the world’s largest country is more in the company of
Botswana.
Good News on AIDS in Africa: Deaths are down, and the heroes of the story
aren’t who you think.<http://www.aidsmap.com/Aggregator.ashx?type=bulletin&url=http%3a%2f%2fwww.slate.com%2farticles%2fhealth_and_science%2fmedical_examiner%2f2013%2f03%2fgood_news_on_aids_in_africa_religious_leaders_help_fight_disease.html&utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>

from Slate

As a single class of people, local religious leaders sit at the very top of
our list of who should receive credit for the behaviour changes that have
curbed the spread of HIV in Africa.
The rise of online STI
dating<http://www.aidsmap.com/Aggregator.ashx?type=bulletin&url=http%3a%2f%2fwww.bbc.co.uk%2fnews%2fmagazine-21955126&utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>

from BBC Health

Dating can often be fraught with uncertainty and self-consciousness. For
those with incurable sexually transmitted infections (STIs), are tailored
websites the answer for people nervous of telling potential partners about
their condition?

 My drugs chart<http://www.aidsmap.com/my-drugs-chart?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
<http://www.aidsmap.com/my-drugs-chart?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>

*My drugs chart*<http://www.aidsmap.com/my-drugs-chart?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>is
a quick and easy way to find information about anti-HIV drugs.

Simply drag and drop the pills you're interested in to review information
about them. You can also personalise the chart with your own treatment
schedule.

Try it today at:
aidsmap.com/my-drugs-chart<http://www.aidsmap.com/my-drugs-chart?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
 Debating PrEP in the gay
community<http://www.aidsmap.com/PrEP-wars-debating-pre-exposure-prophylaxis-in-the-gay-community/page/2572027/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
<http://www.aidsmap.com/PrEP-wars-debating-pre-exposure-prophylaxis-in-the-gay-community/page/2572027/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>

Pre-exposure prophylaxis (PrEP) was approved in the US in July, following
trials showing its efficacy in preventing sexual transmission of HIV.

But, as we find out in this article in the latest edition of *HIV treatment
update*, it remains a controversial addition to the HIV prevention options
available to gay men in the US.

Read more >><http://www.aidsmap.com/PrEP-wars-debating-pre-exposure-prophylaxis-in-the-gay-community/page/2572027/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
 Get set for HIV
treatment<http://www.aidsmap.com/getset?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
<http://www.aidsmap.com/getset?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>

Have you tried our new interactive tool – *Get set for HIV
treatment<http://www.aidsmap.com/getset?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
*?

It is designed to help people think through how they feel about starting
treatment, and identify any questions or concerns they might have.

Find out more below and visit the tool today at
www.aidsmap.com/getset<http://www.aidsmap.com/getset?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
 IAS 2013 <http://www.ias2013.org/>  <http://www.ias2013.org/>

The 7th International AIDS Society (IAS) Conference on HIV Pathogenesis,
Treatment and Prevention will take place in Kuala Lumpur, 30th June-3rd
July 2013.

There are two key dates in April.

If you are planning to attend the conference, register before *18th
April*to avoid the late-fee surcharge. Late-breaker abstract
submission opens on
*3rd April*.

For more information, visit the conference website: www.ias2013.org
 News from CROI
2013<http://www.aidsmap.com/croi2013?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
<http://www.aidsmap.com/croi2013?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>

Visit our conference news
pages<http://www.aidsmap.com/croi2013?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>for
all our reporting from the 20th Conference on Retroviruses and
Opportunistic Infections (CROI 2013), which took place in Atlanta, USA,
earlier this month.

As well as our news reports, you can find our summary news
bulletins<http://www.aidsmap.com/croi2013/Conference-bulletins/page/2571374/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>in
English, French, Spanish, Portuguese, Italian and Russian, selected
news
about CROI from other sources, and selected
tweets<http://www.aidsmap.com/croi2013/Tweets-from-CROI-2013/page/2571377/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
.

www.aidsmap.com/croi2013<http://www.aidsmap.com/croi2013?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
.
 HIV prevention news:
Europe<http://www.aidsmap.com/news/HIV-prevention-news-Europe/page/2518826/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
<http://www.aidsmap.com/news/HIV-prevention-news-Europe/page/2518826/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>

The March edition of *HIV prevention news: Europe* is now available online
in English, French, Spanish, Portuguese and Russian.

You can subscribe to receive future editions by email and read it online here
>><http://www.aidsmap.com/news/HIV-prevention-news-Europe/page/2518826/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>


NAM is an award-winning, community-based organisation, which works from the
UK. We deliver reliable and accurate HIV information across the world to
HIV-positive people and to the professionals who treat, support and care
for them.

Make a donation, make a difference at
www.aidsmap.com/donate<http://www.aidsmap.com/donate?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>

*For more details, please contact NAM*
tel: +44 (0)20 3242 0820
fax: +44 (0)20 3242 0839
email: info at nam.org.uk
web: www.aidsmap.com<http://www.aidsmap.com/?utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>

*NAM Publications*
Registered office: 77a Tradescant Road, London, SW8 1XJ
Company limited by guarantee. Registered in England & Wales, number: 2707596
Registered charity, number: 1011220

To unsubscribe please visit:
http://www.aidsmap.com/page/1492854/<http://www.aidsmap.com/page/1492854/?type=x&utm_source=NAM-Email-Promotion&utm_medium=hiv-weekly&utm_campaign=hiv-weekly>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.resist.ca/pipermail/viva/attachments/20130403/d9ea8dd2/attachment-0001.html>

More information about the Viva mailing list